Search
CELL BANK Website

Back Back
RCB1192 : MDA-MB-453  update : 2018/07/31
CommentHuman breast carcinoma established from an effusion. Application consideration
Comment from the depositor
Terms and conditionsBasically, there is no restriction regarding academic use.
Remarks
Order Form Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, Category I and II, depending on the sort of user institutions and the purposes of use.Please use an appropriate MTA(to see).In case of Restriction "a" or "f", please contact RIKEN BRC(cellbank.brc@riken.jp) regarding any kind of for-profit use.
Basic information Depositor DSMZ
Year of deposit 1995
Animal human < Mammals
Genus Homo
Species sapiens
Gender Female
Tissue breast
Case history breast carcinoma
Classification cancer
History overseas, DMSZ (ACC 65)
Lifespan infinite
Morphology epithelial-like
deposit info
lot info
Medium Medium List
Culture type Adherent cells
Medium and additives L-15 + 10% FBS
Antibiotics Free
Passage method 0.25% trypsin
Culture information Passage ratio 1 : 8 split
SC frequency Subculture : 1-2 times/week, Medium Renewal : 2 times/week
Temperature 37 ℃
CO2 concentration 0 %
Freeze medium Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma (-)
STR (human) OK
Isozyme LD, NP
Chromosome mode 82-108(50) : /86(3),87(1),88(7),89(13),90(17),91(5)/
Images
deposit info
lot info
Reference information Reference 2
User's Publication 22


To topTop
Reference
2041  Cailleau R, Olive M, Cruciger, Q V  Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization.  In Vitro  1978  14:911-5  PubMed ID: 730202
4957  Siciliano MJ, Barker PE, Cailleau R.  Mutually exclusive genetic signatures of human breast tumor cell lines with a common chromosomal marker.  Cancer Res  1979  9(3):919-22  PubMed ID: 427779

To topTop
User's Publication
3019  Akazawa, Akihiko, Nishikawa, Kazuhiro, Suzuki, Kazuyuki, Asano, Ryuji, Kumadaki, Itsumaru, Satoh, Haruna, Hagiwara, Kiyokazu, Shin, Sung Jae, Yano, Tomohiro  Induction of apoptosis in a human breast cancer cell overexpressing ErbB-2 receptor by alpha-tocopheryloxybutyric acid.  Jpn J Pharmacol  2002  89:417-21  PubMed ID: 12233821
3023  Nishikawa, Kazuhiro, Satoh, Haruna, Hirai, Ayako, Suzuzki, Kazuyuki, Asano, Ryuji, Kumadaki, Itsumaro, Hagiwara, Kiyokazu, Yano, Tomohiro  alpha-Tocopheryloxybutyric acid enhances necrotic cell death in breast cancer cells treated with chemotherapy agent.  Cancer Lett  2003  201:51-6  PubMed ID: 14580686
7226  Subramanian N, Kanwar JR, Kanwar RK, Krishnakumar S.  Targeting Cancer Cells Using LNA-Modified Aptamer-siRNA Chimeras.  Nucleic Acid Ther  2015  25:317-22  PubMed ID: 26334953
7287  Iida R, Ueki M, Yasuda T.  Identification of interacting partners of Human Mpv17-like protein with a mitigating effect of mitochondrial dysfunction through mtDNA damage.  Free Radic. Biol. Med.  2015  87:336-45  PubMed ID: 26165189
7842  Takahashi Y, Iwai M, Kawai T, Arakawa A, Ito T, Sakurai-Yageta M, Ito A, Goto A, Saito M, Kasumi F, Murakami Y.  Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer.  Breast Cancer  2011  19:242-52  PubMed ID: 21526423
8681  Shinya Shimoda, Hideaki Ichihara, Yoko Matsumoto, Ryuichi Ueoka  Nanoparticles of Hybrid Liposomes for the Inhibition of Breast Tumor Growth along with Apoptosis  Chemistry Letters  2009  38:134-135 
9109  Satoh H, Nishikawa K, Suzuki K, Asano R, Virgona N, Ichikawa T, Hagiwara K, Yano T.  Genistein, a soy isoflavone, enhances necrotic-like cell death in a breast cancer cell treated with a chemotherapeutic agent.  Res. Commun. Mol. Pathol. Pharmacol.  2005  113-114:149-58  PubMed ID: 15686114
9818  Kanzaki H, Shinohara F, Suzuki M, Wada S, Miyamoto Y, Yamaguchi Y, Katsumata Y, Makihira S, Kawai T, Taubman MA, Nakamura Y.  A-Disintegrin and Metalloproteinase (ADAM) 17 Enzymatically Degrades Interferon-gamma.  Sci Rep  2016  6:32259  PubMed ID: 27573075
9880  Poulose AC, Veeranarayanan S, Mohamed MS, Aburto RR, Mitcham T, Bouchard RR, Ajayan PM, Sakamoto Y, Maekawa T, Kumar DS.  Multifunctional Cu2-xTe Nanocubes Mediated Combination Therapy for Multi-Drug Resistant MDA MB 453.  Sci Rep  2016  6:35961  PubMed ID: 27775048
9925  Fujimoto M, Inoue T, Kito H, Niwa S, Suzuki T, Muraki K, Ohya S.  Transcriptional repression of HER2 by ANO1 Cl- channel inhibition in human breast cancer cells with resistance to trastuzumab.  Biochem. Biophys. Res. Commun.  2017  482:188-194  PubMed ID: 27838298
9992  Khatun A, Fujimoto M, Kito H, Niwa S, Suzuki T, Ohya S.  Down-Regulation of Ca2+-Activated K⁺ Channel KCa1.1 in Human Breast Cancer MDA-MB-453 Cells Treated with Vitamin D Receptor Agonists.  Int J Mol Sci  2016  17:  PubMed ID: 27973439
10445  Yamaguchi H, Ito Y, Miura N, Nagamura Y, Nakabo A, Fukami K, Honda K, Sakai R.  Actinin-1 and actinin-4 play essential but distinct roles in invadopodia formation by carcinoma cells.  Eur. J. Cell Biol.  2017  96:685-694  PubMed ID: 28797528
11228  Ichihara H, Okumura M, Tsujimura K, Matsumoto Y.  Theranostics with Hybrid Liposomes in an Orthotopic Graft Model Mice of Breast Cancer.  Anticancer Res.  2018    PubMed ID: 30275183
4120  Miyagawa Y, Matsushita Y, Suzuki H, Komatsu M, Yoshimaru T, Kimura R, Yanai A, Honda J, Tangoku A, Sasa M, Miyoshi Y, Katagiri T.  Frequent downregulation of LRRC26 by epigenetic alterations is involved in the malignant progression of triple-negative breast cancer.  Int. J. Oncol.  2018    PubMed ID: 29512727
4288  Khatun A, Shimozawa M, Kito H, Kawaguchi M, Fujimoto M, Ri M, Kajikuri J, Niwa S, Fujii M, Ohya S.  Transcriptional Repression and Protein Degradation of the Ca2+-Activated K+ Channel KCa1.1 by Androgen Receptor Inhibition in Human Breast Cancer Cells.  Front Physiol  2018    PubMed ID: 29713287
4376  Fujimoto M, Kito H, Kajikuri J, Ohya S.  Transcriptional repression of human epidermal growth factor receptor 2 by ClC-3 Cl- /H+ transporter inhibition in human breast cancer cells.  Cancer Sci.  2018    PubMed ID: 29949674
5012  Kawakami T, Chano T, Minami K, Okabe H, Okada Y, Okamoto K.  Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma.  Hum Mol Genet  2006  15(6):821-30  PubMed ID: 16439445
5833  Sato M, Muguruma N, Nakagawa T, Okamoto K, Kimura T, Kitamura S, Yano H, Sannomiya K, Goji T, Miyamoto H, Okahisa T, Mikasa H, Wada S, Iwata M, Takayama T.  High antitumor activity of pladienolide B and its derivative in gastric cancer.  Cancer Sci  2014  105(1):110-6  PubMed ID: 24635824
5869  Tatsuya Nodagashira,Hiroki Odagiri,Shojiro-Kazunori Ikenaga,Masaki Maruyama, Toshiyuki Sato and Kenichi Hakamada  Efficient gene transduction in HER2-expressing cancer cells by two recombinant adenovirus vectors with HER2 promoter and Cre/loxP system  Hirosaki Med J  2010  61:26―34 
5877  Yamamoto H, Okumura K, Toshima S, Mukaisho K, Sugihara H, Hattori T, Kato M, Asano S.  FXYD3 protein involved in tumor cell proliferation is overproduced in human breast cancer tissues.  Biol Pharm Bull  2009  32(7):1148-54  PubMed ID: 19571376
6400  Hatano H, Kawashima H, Ogose A, Hotta T, Endo N.  A PCR-ELISA assay for the detection of disseminated osteosarcoma cells in a mouse metastatic model.  J Orthop Sci  2001  6(3):269-75  PubMed ID: 11484122
2763  Ghosh, Mila, Koike, Naoto, Tsunoda, Shin-Ichi, Hirano, Takashi, Kaul, Sunil, Kashiwagi, Hironobu, Kawamoto, Toru, Ohkohchi, Nobuhiro, Saijo, Kaoru, Ohno, Tadao, Miwa, Masanao, Todoroki, Takeshi  Characterization and genetic analysis in the newly established human bile duct cancer cell lines.  Int J Oncol  2005  26:449-56  PubMed ID: 15645130



Back Back Return Top Page